Skip to content
Medical Health Aged Care

ANMF statement on NSW Hospital antisemitic video

Australian Nursing Midwifery Federation (ANMF) < 1 mins read

The Australian Nursing and Midwifery Federation (ANMF) condemns all forms of racism, bigotry and hatred, including acts of antisemitism and Islamophobia. 

We are appalled by the video showing two NSW Health workers making antisemitic comments.

That type of hate is simply unacceptable and cannot be tolerated.

 

Nurses treat people on a needs’ basis, not on race, religion, gender or sexual preference.

 

Nurses and midwives are bound by codes of professional conduct and ethics which require them to care for all people, regardless of their circumstances. 

 

There is no place for this type of behaviour in the professions of nursing and midwifery, in the Australian health system or in our country.

 

As the largest union in the country, representing the professions of nursing and midwifery, we stand for peace, we stand for love and respect for all, and we defend the global human right to healthcare.


About us:

 

The ANMF, with over 326,000 members, is the industrial and professional voice for nurses, midwives and carers in Australia.

ANMF media release authorised by Annie Butler, ANMF Federal Secretary. 1/365 Queen St, Melbourne. 


Contact details:

ANMF media inquiries:

Richard Lenarduzzi 0411 254 390

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.